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Abstract
Purpose: Near-infrared (NIR) fluorescence imaging can provide the surgeon with real-time
visualization of, e.g., tumor margins and lymph nodes. We describe and evaluate the Artemis, a
novel, handheld NIR fluorescence camera.
Procedures: We evaluated minimal detectable cell numbers (FaDu-luc2, 7D12-IRDye 800CW),
preclinical intraoperative detection of sentinel lymph nodes (SLN) using indocyanine green
(ICG), and of orthotopic tongue tumors using 7D12-800CW. Results were compared with the
Pearl imager. Clinically, three patients with liver metastases were imaged using ICG.
Results: Minimum detectable cell counts for Artemis and Pearl were 2×105 and 4×104 cells,
respectively. In vivo, seven SLNs were detected in four mice with both cameras. Orthotopic
OSC-19-luc2-cGFP tongue tumors were clearly identifiable, and a minimum FaDu-luc2 tumor
size of 1 mm3 could be identified. Six human malignant lesions were identified during three liver
surgery procedures.
Conclusions: Based on this study, the Artemis system has demonstrated its utility in
fluorescence-guided cancer surgery.
Key words: Fluorescence-guided, Near-infrared fluorescence, Optical imaging, Artemis,
Camera, Surgery
Introduction
I n surgery, many non-invasive imaging modalities, suchas computed tomography (CT), magnetic resonance
imaging (MRI), single-photon emission computed tomogra-
phy (SPECT), and positron emission tomography (PET), are
used in a preoperative setting for the detection of tumors and
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for surgical planning. Translating these techniques to the
operating room is challenging due to altered body positions
and tissue manipulation. Therefore, the surgeon still mainly
relies on visual inspection and tactile information during
surgery. New intraoperative imaging modalities that support
the surgeon in identifying vital structures and discriminating
healthy from diseased tissues in real-time are needed, which
is especially important for laparoscopic procedures where
the surgeon lacks tactile information.
Near-infrared (NIR) fluorescence-guided surgery (FGS)
is such a novel technique [1, 2]. Compared to SPECT or
PET, NIR fluorescence provides high-resolution images, can
visualize microscopically tumor nodules, and can be tumor-
specific due to targeted exogenous agents [3]. NIR light has
the advantage of increased depth penetration and decreased
autofluorescence compared to visible light [4, 5]. Further-
more, NIR light is invisible to the human eye and
consequently does not alter the surgical field.
The success of FGS in recognizing tumors and vital
structures depends to a large extent on the imaging system
used. In an excellent review, Gioux et al. [6] systematically
described the required criteria to which a new clinically
applicable NIR fluorescence camera system has to comply.
These requirements are translated into a set of practical criteria.
The most important criteria for practical application are
the following: field of view, imaging distance to the patient,
maneuverability, simultaneous imaging of near-infrared and
visible light, real-time imaging, light intensity, sterility, and
electrical safety. These criteria mainly affect the design
choices of the following camera components: sensor, lens
system, light source, and filters/dichroic mirrors.
Currently, a small number of camera systems that fit most of
the criteria above are clinically available [7]. The intraoperative
Artemis imaging system is recently developed within the Center
for Translational Molecular Medicine (CTMM) consortium.
The system is developed in close collaboration with the clinic,
which resulted in an easily maneuverable system (Fig. 1a) that
acquires (NIR) fluorescence and white light images simulta-
neously allowing for a depicted overlay. Furthermore, the
Artemis has an option to assemble a laparoscope to the camera
head, allowing for minimally invasive surgery.
The goal of this work was to evaluate the Artemis camera
in two oncological procedures in which real-time NIR
fluorescence could be of added value: (a) radical tumor
resection and (b) the detection of sentinel lymph nodes, the
first draining nodes from the tumor. Irradical tumor
resections are a major problem in cancer surgery. At present,
although tumors clinically appear to be radically resected,
high percentages of microscopically irradical resections
have been reported at pathological analysis [8, 9]. Such
patients require adjuvant treatment and have higher risk
of tumor recurrence [10, 11]. When performed with an
exogenous tumor-specific ligand, NIR FGS enables
intraoperative guidance of tumor resections. This poten-
tially decreases the relatively high percentages of
irradical tumor resections and locoregional recurrences,
which may lead to increased survival rates and decreased
morbidity [8, 9].
Fig. 1 Artemis NIR imaging system. a The NIR fluorescence imaging Artemis handheld system is positioned on a movable
trolley. Ring light (1) and lens (2) have to be attached to the handheld camera (3) to obtain NIR fluorescence images. Instead of
lens and ring light, a scope (4) can be attached to the handheld camera when minimal invasive surgery is applied. b Schematic
representation of the Artemis camera with light path and filters. The sample is illuminated by a ring light around the camera lens.
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The detection of the SLN is of vital importance for cancer
staging and consequently influences the choice of therapy
and therefore the survival rates. In breast cancer and
melanoma surgery, the SLN procedure is presently the
standard of care [12]. Currently, two exogenous contrast
agents are clinically available: indocyanine green (ICG) (800
nm) and methylene blue (700 nm). Both non-specific
contrast agents are used for the visualization of SLNs, vital
structures, and various tumors in the clinic [12].
In this study, we performed a preclinical assessment of
the sensitivity and intraoperative utility of the Artemis in the
detection of head-and-neck tumors and SLNs preclinically in
xenograft mouse models.
Images were simultaneously acquired with the Pearl
Impulse Small Animal Imager (LI-COR), an existing
commercially available and commonly used imaging system.
The Pearl system is expected to be an order of magnitude
more sensitive than the Artemis, and therefore, these images
serve as a ground truth comparison. The Pearl camera does
not allow real-time imaging. The sample is shed from
outside light imaging in a closed box. Although benefitting
the image quality, the latter two characteristics prevent
application of the Pearl for intraoperative (pre-)clinical
imaging. The Artemis imaging system allows real-time
imaging and free access to the sample, but imaging takes
place at less ideal circumstances than in the Pearl.
We report the first in-human study performed with the
Artemis imaging system where colorectal liver metastases
were visualized using ICG.
Methods
Near-Infrared Camera Systems
The Artemis camera system was developed by Quest Medical
Imaging and the Leiden University Medical Center (Fig. 1). Images
were acquired using custom-designed cameras in a portable, freely
moveable camera head. A wide field lens for open surgery was
used. Samples were illuminated from a ring containing optical
fibers (Fig. 1a-1) attached to the lens (Fig. 1a-2) during open
surgery imaging.
A Lumencor light engine was used containing four solid-state
light sources for visible light illumination with peak intensities in
the blue, cyan, green, and red. For NIR fluorescence imaging, an
NIR laser with a peak intensity at 785 nm was used for the
preclinical and at 793 nm for the clinical system. The intensities of
the light sources could be controlled from the Artemis software. A
sterilizable optical fiber was used to connect the light engine to the
illumination ring.
Reflected light was captured in the camera head as depicted in
Fig. 1b. Reflected excitation light is blocked by a 750–800-nm
notch filter. Subsequently, the light passes through a lens that could
be used for focusing. The light then enters a prism containing a
dichroic coating (G785 mm) in order to separate visible and NIR
light. The visible light passes through a low-pass filter (G640 nm)
and the NIR light through a high-pass filter (9808 nm). Both light
beams are captured by a Sony ICX618 sensor with Bayer
configuration having a 640×494 pixel grid.
Exposure times and sensor gains were separately adjusted for
both imaging channels, and acquisition was synchronized to the
longest exposure time. The raw data of both sensors could be saved
as individual snapshots or as a real-time movie. During procedures,
the visible light channel, the NIR fluorescence channel, and an
adjustable overlay are presented.
The Pearl Impulse uses two lasers for excitation with a
wavelength of 685 and 785 nm. In this work, only the 785-nm
excitation light is used. The Pearl camera automatically optimizes
exposure times. Imaging data is acquired with a thermoelectrically
cooled CCD sensor.
Near-Infrared Probe(s)
The Artemis was evaluated in two imaging procedures in which
fluorescence-guided surgery could be of added value. The clinically
available ICG (Pulsion Medical Systems, Munich, Germany, λex=
780 nm, λem=820 nm) is frequently used in SLN mapping and for
that the choice of dye in this study. IRDye 800CW (LI-COR,
Lincoln, NE, USA, λex=774 nm, λem=789 nm) was chosen because
it is one of two novel fluorophores in the process of clinical
translation [2]. Two imaging procedures were evaluated because of
the differences in fluorophores and mainly because fluorophore
concentration differs at the side of interest. The near-tumoral
injected ICG is highly concentrated compared to the intravenously
injected IRDye 800CW conjugated to a targeting moiety. Further-
more, ICG and IRDye 800CW differ in excitation and emission
spectra and have different quantum yields.
ICG was resuspended in Cealb (20 % human serum albumin,
Sanquin, Amsterdam, The Netherlands) to obtain a dilution from 1
mM to 100 fM. Clinically, 25 mg ICG was resuspended in 10 ml of
sterile water before injection obtaining a stock solution of 2.5
mg/ml (3.2 mM). Of this, 4 ml, corresponding to a dose of 10 mg,
was administered intravenously.
IRDye 800CW carboxylate was resuspended in phosphate-
buffered saline to obtain a dilution from 1 μM to 100 fM. Tumor-
specific imaging experiments were done using the epidermal
growth factor receptor-specific nanobody 7D12 with the non-
epidermal growth factor receptor (EGFR)-specific nanobody R2 as
a control [13, 14]. The generation of the nanobodies 7D12 and R2
and the conjugation to the NIR fluorophore IRDye 800CW were
done as described previously [15–17].
Cell Lines
Two human cancer cell lines were used: FaDu-luc2 (human
hypopharyngeal squamous cell carcinoma) and OSC-19-luc2-cGFP
(metastatic oral squamous cell carcinoma). Both were cultured as
previously described [1, 14].
Camera Characterization In Vitro
Calibration of Camera SystemConcentration series of both NIR
fluorophores were used to estimate the concentration-dependent
sensitivity.
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ICG was dissolved in human serum albumin (HSA) in
concentrations from 1 mM to 100 fM. HSA without ICG served
as a control. IRDye 800CW was dissolved in PBS in concentrations
of 1 μM to 100 fM. PBS without IRDye 800CW served as a
control.
One hundred microliters of each concentration was added to a
96-well plate and experiments were performed in duplicate. All
series were imaged using both Pearl and the Artemis (with
exposure times of 60 ms, to ensure real-time imaging).
Cell ExperimentsFaDu-luc2 cells were cultured in T75 culture
flasks until subconfluence. After washing with binding medium
(MEM supplemented with 25 mM Hepes and 1 % BSA, at pH 7.2),
20 ml of binding medium with 50 nM 7D12-800CW was added.
Cells were incubated in the dark, for 2 hours in a humidified
incubator at 37 °C and 5 % CO2. Cells were harvested with a
solution of 10 % trypsin in PBS. Subsequently, cells were washed
in medium and adjusted to a suspension containing 2×106 cells.
This suspension was diluted ten times in a 1:2 ratio in medium and
aliquoted in 500-μl tubes. Tubes were centrifuged with 13,000 rates
per minute, and after the aspiration of medium, cell pellets were
imaged with the Pearl and Artemis camera system. After imaging,
cells were resuspended in 50 μl of PBS containing 2 μl of D-
luciferin solution (Syncem, Inc. Elk Grove Village, IL) followed by
bioluminescence imaging (BLI) using the IVIS Spectrum imaging
system (Caliper Life Sciences). Quantification of the BLI signal
was performed through standardized regions of interest using
Living Image software (Caliper Life Sciences). The experiment
was performed in duplicate and cells incubated with medium served
as a negative control [18]. The same dilutions of cells were made
without incubation of 7D12-800CW to correlate the BLI signal to
the number of cells (Fig. 2e).
Camera Characterization In Vivo
Animal ModelsAnimal experiments were performed in female
nude Balb/c mice (Charles River laboratories, l’Arbresle, France)
aged 4–6 weeks. Mice were housed in individually ventilated cages
and provided with food and sterilized water ad libitum. During the
experiments, general health was monitored by weight measure-
ments and tongue inspections. Imaging procedures were performed
under isoflurane gas anesthesia (5 % induction and 2 %
maintenance). The local animal welfare committee of the Leiden
University Medical Center approved the animal experiments.
In order to induce subcutaneous xenografts of hypopharyngeal
squamous cell carcinomas, mice were inoculated at four spots on
the back with 1, 2, 3, and 4×106 FaDu-luc2 cells, diluted in 50 μl
PBS. Tumor growth was monitored twice a week with BLI. At day
10, mice were randomly allocated to injection with 7D12-800CW
or R2-800CW.
Orthotopic tongue tumors were induced in the tip of the tongue
through a submucosal injection of 40,000 OSC-19-luc2-cGFP cells,
diluted in 10 μl phosphate-buffered saline. Twice a week, mice
body weight was monitored, tongues were inspected, and BLI was
measured. At day 20, mice were randomly allocated to injection of
7D12-800CW or R2-800CW. BLI signals served as a control for
the tumor specificity of the probe.
Sentinel Lymph Node Detection Using ICGPrecontrast images
were taken with the Artemis and Pearl imaging systems to obtain
background signal intensities of the tissue of interest. The Artemis
was configured to image in real time (exposure time of 40 ms).
After positioning of the mice (n=4), 10 μl of 100 μM ICG and
HSA was injected submucosally in the tip of the tongue. NIR
fluorescence imaging of ICG was performed at 0, 5, 10, 15, and 20
min after injection with both the Pearl and Artemis imaging
systems. After 20 min, the skin of the cervical region was removed
and images were taken. Subsequently, cervical lymph nodes were
removed under NIR fluorescence guidance of the Artemis imaging
system.
Tumor-Specific Imaging Using 7D12-800CW FaDu-luc2 mice
were randomly allocated to the intravenous injection of 7D12-
800CW (3.2 nmol, n=4) or R2-800CW (3.0 nmol, n=3). After an
incubation of 24 h, imaging was performed using both imaging
systems. Tumors of mice injected with 7D12-800CW were excised
with direct guidance of the real-time fluorescence signal of the
Artemis (exposure time 60 ms). All excised tumors were imaged
ex vivo with both imaging systems, and tumor volume was
determined by measuring the width (W), length (L), and height
(H) of each tumor using a digital caliper. Tumor volume was
calculated by using the ellipsoid volume formula π /6×L×W×H
[19]. Four tumors of mice injected with 7D12-800CW were cut in
half and subsequently divided into halves until submillimeter tumor
parts were obtained after which NIR fluorescence images were
acquired. Muscle tissue was used as a control.
When OSC-19-luc2-cGFP tumors were visible by the human
eye and BLI signal ranged between 5×109 and 1×1010 relative
light units (RLU), 7D12-800CW (3.2 nmol, n=3) or R2-800CW
(3.0 nmol, n=3) was intravenously injected. Whole body fluores-
cence imaging with the Pearl and Artemis was performed after 24 h
of incubation. Subsequently, all tongue tumors were resected under
direct fluorescence guidance of the Artemis camera system.
Histology and Fluorescence Microscopy
The resected hypopharyngeal squamous cell carcinomas and tongue
tumors were cut in two, one half was snap frozen in isopentane and
stored at −80 °C. The other half was fixed in formalin overnight
and embedded in paraffin. Frozen or paraffin tissue sections of
10μm were air-dried, and fluorescence imaging was performed
using the Odyssey (LI-COR) to confirm tumor specificity of 7D12-
800CW. Histologic sections were stained with standard hematox-
ylin–eosin stain (HE). The presence of OSC-19-luc2-cGFP and
FaDu-luc2 cells was confirmed by staining the sections with anti-
human wide spectrum cytokeratin staining (Abcam Inc., Cam-
bridge, MA, USA).
Human Liver Metastases
Three patients with suspected colorectal liver metastases, based
on a preoperative four-phase CT scan (Aquilion 64; Toshiba,
Tokyo, Japan) of the thorax and abdomen, who were planned
to undergo surgery with curative intent, were included.
Exclusion criteria were pregnancy, lactation, or an allergy to
iodine, shellfish, or ICG. Patients received 10 mg of ICG,
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diluted in 4 ml sterile water, as an intravenous bolus at 24
h prior to surgery. After exploration, the liver was first visually
inspected and palpated then intraoperative ultrasound imaging
was performed to locate the liver metastases. Subsequently, all
liver segments were imaged using the Artemis imaging system.
Patients were provided with informed consent, and the study
was approved by the Local Medical Ethics Committee of the
Leiden University Medical Center, Leiden, The Netherlands and
was performed in accordance with the ethical standards of the
Helsinki Declaration of 1975.
Statistical Analysis
All acquired images were analyzed by annotating regions of interest
(ROI). During in vitro acquisitions, the background ROI was
positioned at a location of homogeneous intensity without tissue.
For the in vivo acquisitions, one background ROI was taken on the
animal, next to the structures of interest. Furthermore, a ROI was
drawn on a dark area outside the animal or sample for camera
background correction.
In each acquisition, mean foreground μf and background μb
signals were measured within the ROIs. The camera noise σn was
estimated as the standard deviation with the annotated homoge-
neous areas.
Each acquisition is characterized by three measures:
1. Signal-to-noise ratio (SNR): μf /σn. This indicates how
well signals of a particular intensity can be detected.
2. Contrast-to-noise ratio (CNR): (μf−μb)/σn. This indicates
how well different regions can be identified.
3. Signal-to-background ratio (SBR): μf/μb. This measure is
often reported in the literature to evaluate (tumor) marker
specificity.
In this work, CNR is mainly used to evaluate the Artemis
camera system. This is different than the SBR used in many probe-
binding studies. While SBR is essentially a measure for the uptake
of a probe, it does not measure how well a camera system is
capable of capturing the contrast between tissues with different
probe uptake. For the latter, it is essential to take the camera noise
into account. A tumor with a high SBR may be almost invisible
when imaged with a camera with high noise levels, while a very
low SBR may be discernible very well when camera noise is low.
Measurements with minimal CNR=2 were considered reliable.
This corresponds to a limit of detection (LOD) defined as the
control or background intensity plus two times the noise level.
The SNR, CNR, and SBR for Pearl and Artemis were subjected
to a Wilcoxon rank-sum test or U-test for non-normally distributed
data.
Results
Camera Characterization In Vitro
Calibration of Camera System Acquisitions of 96-well
plates with concentration series of ICG and 800CW were
compared between the Artemis and Pearl camera systems
based on SNR (Fig. 2a, c) and SBR (Fig. 2b, d). CNR is in
this experiment very similar to SNR. The SNR and SBR
curves for ICG from the Pearl show an increase in SNR and
SBR for increasing concentrations up to 10 μM. After this,
peak quenching takes place, causing a decrease in intensity.
The SNR and SBR for the Artemis peak earlier. This is,
however, due to sensor saturation (i.e., values of 255, the
high end of the dynamic range) for the fixed exposure time
of 60 ms. For shorter exposure times, higher concentrations
could be imaged within the dynamic range. For the lower
concentrations, the SNR and SBR curves flatten off at a
higher concentration than for the Pearl, indicating 10−2 μM
as the lower boundary for reliable ICG detection. The SBR
for low concentrations of ICG for the Artemis is about 100
instead of 1. This is due to bright reflections of the excitation
light in the well plates that penetrates through the emission
filter. These reflections were visible in wells with low
concentrations of fluorophore as well as the control well and
showed the eight bright spots that corresponded to the fiber
ends in the illumination ring. The plot in Fig. 2a shows that
within the dynamic range of the Artemis at 60 ms exposure
time, SNRs are comparable between Artemis and Pearl. P-
values for the U-test were P=0.75 and P=0.09, respectively.
Figure 2c, d shows similar results for the 800CW
concentration series as for the ICG concentration series.
Bright reflections of the excitation light again cause high
SNRs and SBRs for low 800CW concentrations, while the
sensor was saturated for 10 μM of 800CW. The minimum
detectable concentration of 800CW is again 10−2 μM.
However, as for the ICG, the excitation light reflections
may prevent detection of lower concentrations. P-values for
the U-test were P=0.04 (SNR) and P=0.01 (SBR). These
significant differences can be attributed to both a smaller
dynamic range of the Artemis, as well as a higher minimally
detectable concentration.
Cell Line Experiments Flow cytometry showed EGFR
expression of FaDu-luc2 cells (data not shown). The
experiment to determine the minimal detection limit of
FaDu-luc2 cells was performed using the EGFR-specific
nanobody 7D12-800CW and the non-EGFR-specific R2-
800CW as a control. The total intensities of fluorescence
measured for 7D12-800CW show agreement between
Artemis and Pearl (Fig. 2f). Also, although clearly not a
linear relationship, both cameras measure an increased
amount of total fluorescence for a larger number of cells,
as indicated by a higher bioluminescent signal. For the non-
specific R2-800CW, both cameras show no relation between
bioluminescence and total intensity (Fig. 2g). The Artemis
total intensities were higher for the R2-800CW experiment
than for the low bioluminescent cell pellets with 7D12-
800CW, while Pearl total intensities are comparable. We
attribute this (small) variation to variations in sample
placement under the Artemis. The minimum amount of cells
that could be detected with the Artemis was extrapolated
from the bioluminescence signal (Fig. 2e) and proved to be
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approximately 2×105 cells and 4×104 cells using the
Artemis and Pearl, respectively.
Camera Characterization In Vivo
Sentinel Lymph Node Detection Using ICG Using both the
Artemis and Pearl camera, seven SLNs were detected in vivo
in four mice. All lymph nodes were visible within 10 min
after injection. Massaging the injection spot could have
expedited this process. After removal of the skin, all eight
lymph nodes were visible. The initially invisible lymph node
was covered by strongly absorbing tissue and was visible
after removal of skin. Figure 3 shows NIR fluorescence
images acquired with Artemis and Pearl after ICG injection
in the tongue, as well as overlays with reflectance images.
The distribution of ICG in the lymph node, as well as the
lymphatic ducts, is clearly visible using both camera
systems. CNRs are computed for each lymph node, where
the background ROI is positioned between the front paws of
the mouse. The mean CNR (Pearl 833, Artemis 225) and
standard deviations (Pearl 584, Artemis 96) for the seven
detected lymph nodes with closed skin are shown in Fig. 3.
Signal-to-background ratios were 126 (standard deviation
(SD) 59) for the Pearl and 1,260 (SD 691) for the Artemis.
This difference was mainly due to low background signals,
where the Pearl background was relatively higher. SBR is an
unreliable measure when the background signal is low. The
U-test P-values showed significant differences for both CNR
(P=0.010) and SBR (PG0.001).
Tumor-Specific Imaging Using 7D12-800CW, Tongue Tu-
mor Model Orthotopic EGFR-overexpressing (data not
shown) OSC-19-luc2-cGFP tongue tumors were clearly
identifiable using both Artemis and Pearl after injection of
7D12-800CW (Fig. 4). Bioluminescence confirmed the
location of the tumor, and there was colocalization between
fluorescence and bioluminescence signals. No fluorescence
was observed with the control nanobody R2-800CW. CNRs
for both Artemis and Pearl are 101 (SD 55) and 143 (SD 15)
for 7D12-800CW, while a low fluorescence signal was
detected for R2-800CW with CNRs 12 (18) and 18 (25) for
Artemis and Pearl, respectively. The larger standard devia-
tion in CNR of 7D12-800CW for the Artemis than for the
Pearl could be attributed to inhomogeneous lighting con-
ditions in the Artemis camera setup. In an open camera
setting, a lower amount of excitation light tends to reach the
tissue of interest, leading to excitation of a lower amount of
fluorophore resulting in a lower excitation fluorescence
signal that can be detected [5]. The large standard deviation
Fig. 2 Calibration of the Artemis system and minimal detection limit of hypopharyngeal tumor cells. a, c Signal-to-noise (SNR)
and b, d signal-to-background (SBR) ratios of concentration ranges of a, b ICG and c, d CW800 imaged in 96-well plates.
Measurements from control wells with 0 μM ICG and CW800 are shown as red horizontal lines. e Bioluminescence was
correlated to the number of FaDu-luc2 cells. f FaDu-luc2 cells were incubated with the EGFR-specific nanobody 7D12-800CW
and g non-specific nanobody R2-800CW for 2 hours. After incubation, cells were washed twice and cell pellets containing
different amount of cells were imaged using the Artemis and Pearl imaging system.
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is reflected in the differences in CNR of 7D12-800CW and
R2-800CW between the Artemis and Pearl with P=0.7 and
P=0.4, respectively. The CNR between 7D12-800CW and
R2-800CW was statistically significantly different for the
Pearl (P=0.017) but not for the Artemis (P=0.13). The
larger standard deviation in CNR of 7D12-800CW for the
Artemis could partly be attributed to inhomogeneous
lighting conditions in the Artemis camera setup. Further-
more, due to short acquisition times in an intraoperative
imaging setting, a smaller amount of fluorescent photons are
captured per acquired frame, leading to noisier images.
Lastly, the Artemis system does not have a cooled camera,
increasing sensitivity to thermal noise.
Tumor-Specific Imaging Using 7D12-800CW, Hypophar-
yngeal Tumor Model Subcutaneous FaDu-luc2 tumors
could be clearly imaged with both the Artemis and Pearl
Fig. 3 Sentinel lymph node detection using indocyanine green. Cervical sentinel lymph nodes could clearly be identified after
injection of 100 μM ICG (10 μl) in the tongue (T) using both the Artemis and Pearl imaging system within 10 min after injection.
Contrast-to-noise ratios (CNR) of the Artemis and Pearl are shown. LNL = lymph node left; LNR = lymph node right.
Fig. 4 Near-infrared fluorescence delineation of orthotopic tongue tumors. OSC-19-luc2-cGFP tongue tumors could clearly be
identified after injection of the epidermal growth factor receptor-specific nanobody 7D12-800CW (50 μg) using both the Artemis
and Pearl. No fluorescence could be observed after injection of 50 μg of control nanobody R2-800CW. Contrast-to-noise ratios
(CNR) calculated by using the Artemis and Pearl are shown. A = Artemis; P = Pearl.
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camera after injection of 7D12-800CW. Histology con-
firmed tumor specificity of 7D12-800CW (Supplementary
Fig. 1). Figure 5 shows the bioluminescent signal (a) that
confirms the tumor presence and overlays from the Artemis
(b) and Pearl (c). The Artemis overlay shows a high signal
between the kidneys, while the Pearl overlay does not show
this signal. In contrast to the Artemis, for the Pearl, the
overlay can be adjusted to show that the tumors fluoresce
stronger than the center of the back of the mouse where
scattering increases fluorescence signal next to the kidneys.
For the Artemis, the large spatial variation in illumination
intensity caused a non-significant difference between SBRs
for tumors with 7D12-800CW and R2-800CW (P=0.09),
while the difference for the Pearl was significant (PG0.001)
(Fig. 5f).
Figure 5d, e show an example of a halved tumor with
7D12-800CW imaged with both Artemis (d) and Pearl (e).
In the Artemis overlay, part of a ruler is visible. For each
tumor piece, the volume is estimated and the relation
between CNR and volume is shown in Fig. 5g. Muscle
tissue was included as an additional control. A clear relation
between tumor volume and CNR is visible for 7D12-800CW
for both Artemis and Pearl, where the Pearl in general
showed a higher CNR and the Artemis a larger spread. The
CNRs were significantly different for both 7D12-800CW
(PG0.001) and R2-800CW (PG0.001). Fluorescence of
tumor pieces with a CNR below 2 is practically invisible
by eye (depicted by the gray horizontal line). Five tumor
pieces were below this line for the Artemis, while these
tumor pieces were hardly visible with the Pearl. The tumor
pieces missed by the Artemis had an average size in the
order ≤1 mm3. Although smaller pieces in general had a
lower CNR, a size of 1 mm3 should be considered as the
lower boundary, as the majority of tumor pieces of this size
were visible by both cameras.
Contrast-to-noise ratios are significantly different be-
tween specific and non-specific probes for both Artemis
(PG0.001) and Pearl (PG0.001).
Human Liver Imaging
Three patients with liver metastases were imaged using the
Artemis camera system during surgery. All three patients
had metastases from colon tumors near or at the liver
surface. Figure 6 illustrates the combination of images such
Fig. 5 Tumor detection limit. Hypopharyngeal FaDu-luc2 tumors of different sizes visualized using bioluminescence imaged by
a the IVIS Spectrum system could clearly be delineated in vivo using both b the Artemis and c Pearl. fIn vivo tumor signal-to-
background ratios (SBR) were calculated. Twenty-four hours after injection of 7D12-800CW and R2-800CW, all tumors were
repeatedly halved until submillimeter size. Tumor pieces were measured using the d Artemis and e Pearl. g Contrast-to-noise
ratios (CNR) were plotted against the volume of the tumor pieces. Ruler lines denote millimeters. K = kidney; T = tumor; M =
muscle; A = Artemis; P = Pearl.
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as presented to the surgeon: visible light (Fig. 6a), NIR
fluorescence signal (Fig. 6b), and a real-time overlay (Fig.
6c). The metastases in this example are recognizable due to
their fluorescent rim. Benign lesions could be differentiated
from malignant lesions by a lack of this fluorescent rim
around the tumor, as was confirmed by pathologic analysis
[20]. A total of six lesions with fluorescent rim were
identified during surgery with NIR fluorescence, and all
showed to be malignant after pathologic evaluation. No
false-negative nodules were found. One lesion in segment 6
of the liver was initially missed by eye but was clearly
visualized using the Artemis system.
Discussion
Fluorescence-guided surgery is a high potential imaging
technique that provides surgeons with real-time information
about vital structures, tumor margins, and regional dissem-
inated disease. By real-time feedback of tumor margins and
vital structures, tumors could be radically resected while
healthy tissue can be preserved. A dedicated NIR fluores-
cence camera is vital as NIR light is invisible to the human
eye. In this study, we evaluated the Artemis NIR fluores-
cence camera system. Its performance in detecting ICG and
IRDye 800CW was assessed and was put in perspective by
comparison with the preclinical Pearl imaging system.
Furthermore, we demonstrated its utility in detecting and
guiding resection of cervical SLNs using ICG, as well as
primary tongue tumors and hypopharyngeal tumors using an
EGFR-targeting nanobody conjugated to IRDye 800CW.
Next, first in-human clinical data using the Artemis was
shown by the detection of liver metastases using ICG.
The efficacy of NIRF camera systems and the final real-
time fluorescence imaging results are dependent on multiple
factors. These factors include the interplay between the type
of probe or fluorophore used, probe concentration injected,
concentration of probe at the location of interest, tumor size,
optical properties, and the camera system.
The Artemis was evaluated for the use in two frequently
used FGS procedures because there is a major difference in dye
and in concentration of dye at the site of interest between both
procedures. The near-tumoral injected ICG in SLN mapping is
highly concentrated compared to the intravenously injected
conjugate of IRDye 800CW and a targeting moiety in tumor-
specific imaging. Furthermore, ICG and IRDye 800CW differ
in excitation spectra, emission spectra, and quantum yield. In
general, imaging results are more adequate when a fluorophore
has a high quantum yield and there is a high concentration at
the site of interest.
The second variable that intervenes with the efficacy of a
NIRF camera is the injected concentration of probes. For the
experiments in vivo, the optimal concentration was chosen. The
optimal concentration of ICG was extrapolated from the ICG
dilution series in vitro. In the choice of the injected dose in vivo
(100 μM), dilution of ICG after intratumoral injection was taken
into consideration. Concentrations of 7D12-800CW (50 μM)
and R2-800CW (μM) were chosen from earlier studies [14].
Next, the size of the tumor determines the imaging results.
We assessed the detection limit of a FaDu-luc2 tumor nodule
size that could be detected using the nanobody 7D12-800CW.
For that, tumor pieces were subdivided into halves until
submillimeter size. Since 7D12-800CW is homogenously
distributed throughout the tumor [13, 14] (Supplementary
Fig. 1), subdivision was justified. A size of 1 mm3 could be
considered as the lower boundary of detection, as the majority
of tumor pieces of this size were visible. A tumor size of 1 mm3
is considered to contain around three million tumor cells. Using
this setup, lower amount of cells that could be clinically
significant would not be detected. Obviously, a detection limit
is dependent on multiple factors like the probe that is used, the
observer, the concentration and pharmacokinetics of the probe,
the target that is chosen, and the amount of receptors in the
tissue of interest. Furthermore, in vivo, the optical properties of
the tissue of interest and overlaying tissue determine in a great
extent what size of tumor tissue can be detected. Again, results
were compared to the Pearl to validate the Artemis data.
Fig. 6 Near-infrared fluorescence imaging of colorectal liver metastases: 24 h after injection of 10 mg indocyanine green,
colorectal liver metastases could clearly be identified by a rim around the tumor (I and II). Benign lesion (III) could be identified
by fluorescence without the rim. Images are depicted in a visible light, b NIR fluorescence signal, and c a real-time overlay.
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Despite successful utility of the Artemis in our preclinical
experiments and the successful utility of the Artemis in a
clinical setting, several improvements can be made to
increase the applicability and imaging reliability. First, the
illumination intensity as projected by the Artemis sharply
decreases near the edge of the imaged field. This causes the
apparent fluorescence intensity to have a strong dependence
on the location in the image. In the experiment using cell
lines in vitro, we showed that both the Artemis and Pearl
were able to image the same relationship between number of
cells and intensity for the tumor-specific 7D12-800CW
probe. For the non-specific R2-800CW, both cameras
showed a flat profile. The Artemis signal was less consistent
than that of the Pearl for low cell counts with 7D12-800CW
and for the cells with R2-800CW. This can be attributed to a
less inhomogeneous illumination of the sample than for the
Pearl. Precise positioning of the sample when comparing
fluorescence intensities is thus essential for the Artemis
while less critical for the Pearl. This spatial illumination
variation is also visible in Fig. 5f, as a large standard
deviation on the SBRs for the in vivo tumors resulting in a
non-significant difference between SBRs for tumors with
7D12-800CW and R2-800CW (P=0.09).
Second, a possible improvement lies in filtering the
excitation light. The filters that are intended to block the
excitation light do not block most specular reflections. If
available, filters with a higher optical density would solve
this problem or cross-polarization could be used. Results of
the impairment in blocking reflections can be seen in the
baseline experiment for evaluating the sensitivity of the
Artemis system that consisted of measuring the signal from
fluorophores in concentration series. For the real-time setting
of 60 ms exposure time per image, the Artemis was able to
measure concentrations of both ICG and 800CW of 10−2 μM
and higher. The control Pearl camera showed that fluoro-
phores were present in wells with lower concentrations. This
lower boundary was not solely due to sensitivity limits of the
Artemis camera but also due to reflected excitation light that
was not sufficiently filtered out. For concentrations smaller
than 10−2 μM, these reflections were stronger than the
fluorescence signal.
Third, the current camera has a rather low depth of field.
Since the camera does not have an autofocus mechanism,
this requires frequent adjustment of the focus. An additional
problem with the current Artemis camera systems is a focal
length difference between the visible light and near-infrared
channels. This requires changing the focus between a sharp
visible light and near-infrared fluorescence image at close
imaging distances (G15 cm).
A last possible improvement is the dynamic range of the
camera. This lack of range is visible in the images with
concentration ranges; only a few concentrations are between
the lower detection boundary and the saturation boundary.
Although such a wide variation in concentrations is not to be
expected in clinical applications and overexposure is not a
big issue, large variations in working distance during surgery
also lead to large intensity variations of the fluorescence
signal. The visible light channel also tended to be over-
exposed, even at the least sensitive camera settings.
Conclusion
NIR fluorescence-guided surgery could aid surgeons in
real-time visualization of tumors, SLNs, and vital
structures to ensure a radical resection, adequate staging,
and minimize damage to normal tissue. In this study, we
evaluated the Artemis system and assessed the minimal
detection limit of tumor-specific imaging using an
EGFR-targeting nanobody. Furthermore, we demonstrated
the possibility of fluorescence-guided resection of head
and neck tumors and sentinel lymph nodes. At last, we
demonstrated the use of the Artemis system for the
detection and fluorescence-guided resection of liver
metastases in a first in-human clinical trial. Based on
this study, although improvements can be made, we
think the Artemis system has demonstrated its utility in
fluorescence-guided cancer surgery.
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